Ronghua Wang
Net Worth

Last updated:

What is Ronghua Wang net worth?

The estimated net worth of Mr. Ronghua Wang is at least $227,649 as of 16 Jun 2011. He owns shares worth $9 as insider and has received compensation worth at least $227,640 in Biostar Pharmaceuticals, Inc..

What is the salary of Ronghua Wang?

Mr. Ronghua Wang salary is $16,260 per year as Chairman, Chief Executive Officer & Pres in Biostar Pharmaceuticals, Inc..

How old is Ronghua Wang?

Mr. Ronghua Wang is 69 years old, born in 1956.

What stocks does Ronghua Wang currently own?

As insider, Mr. Ronghua Wang owns shares in one company:

Company Title Shares Price per share Total value
Biostar Pharmaceuticals, Inc. (BSPM) Chairman, Chief Executive Officer & Pres 9,166,973 $0 $9

What does Biostar Pharmaceuticals, Inc. do?

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Ronghua Wang insider trading

Biostar Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 13,800 $1.1 $15,180
Purchase
Common Stock 14,350 $1.19 $17,077
Purchase
Common Stock 35,100 $1.23 $43,173
Purchase
Common Stock 22,050 $1.24 $27,298
Purchase
Common Stock 19,700 $1.21 $23,739
Purchase
Common Stock 12,000 $1.22 $14,664
Purchase
Common Stock 34,600 $1.26 $43,700
Purchase
Common Stock 8,600 $1.25 $10,750
Purchase
Common Stock 10,300 $1.24 $12,772
Purchase
Common Stock 6,900 $1.27 $8,763
Purchase
Common Stock 12,200 $1.29 $15,738
Purchase
Common Stock 9,312 $1.34 $12,497

Biostar Pharmaceuticals key executives

Biostar Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Mr. Ronghua Wang (69) Chairman, Chief Executive Officer & Pres
  • Mr. Zhenghong Wang (45) Chief Operating Officer